Lack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man.
作者信息
Gulaid A, James I M, Kaye C M, Lewellen O R, Roberts E, Sankey M, Smith J, Templeton R, Thomas R J
出版信息
Br J Clin Pharmacol. 1978 Mar;5(3):261-2. doi: 10.1111/j.1365-2125.1978.tb01634.x.
Abstract
摘要
相似文献
1
Lack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man.乙酰化状态与人中醋丁洛尔乙酰代谢物生成之间缺乏相关性。
Br J Clin Pharmacol. 1978 Mar;5(3):261-2. doi: 10.1111/j.1365-2125.1978.tb01634.x.
2
Acebutolol pharmacokinetics in renal failure.醋丁洛尔在肾衰竭中的药代动力学。
Br J Clin Pharmacol. 1983 Sep;16(3):253-8. doi: 10.1111/j.1365-2125.1983.tb02158.x.
3
The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).盐酸醋丁洛尔单次口服给药（400毫克）后，以及多次口服给药期间和之后（400毫克，每日两次）在人体中的药代动力学。
Biopharm Drug Dispos. 1981 Apr-Jun;2(2):103-14. doi: 10.1002/bdd.2510020202.
4
Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man.醋丁洛尔及其主要代谢产物在血浆和尿液中的定量分析以及对其在人体处置动力学的初步观察。
Res Commun Chem Pathol Pharmacol. 1976 Sep;15(1):31-51.
5
Preliminary observations on the excretion of acebutolol and its acetyl metabolite in the urine and faeces of man.
J Pharm Pharmacol. 1981 Jun;33(6):386-7. doi: 10.1111/j.2042-7158.1981.tb13811.x.
6
Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.肾功能损害患者中醋丁洛尔及其乙酰代谢物的血浆和尿液浓度。
N Z Med J. 1980 Apr 23;91(658):289-91.
7
Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.使用一种新的立体选择性高效液相色谱法对醋丁洛尔及其代谢物双醋洛尔在人体中的处置进行的初步研究。
J Pharm Pharmacol. 1984 Apr;36(4):276-7. doi: 10.1111/j.2042-7158.1984.tb04370.x.
8
9
A proposed mechanism for the adverse effects of acebutolol: CES2 and CYP2C19-mediated metabolism and antinuclear antibody production.醋丁洛尔不良反应的一种推测机制：CES2和CYP2C19介导的代谢及抗核抗体产生。
Biochem Pharmacol. 2015 Dec 15;98(4):659-70. doi: 10.1016/j.bcp.2015.09.016. Epub 2015 Sep 25.
10
A thin-layer chromatographic method for the determination of acebutolol and its major metabolite in serum.一种用于测定血清中醋丁洛尔及其主要代谢物的薄层色谱法。
J Chromatogr. 1976 May 26;120(2):465-72. doi: 10.1016/s0021-9673(76)80023-4.
引用本文的文献
1
Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.醋丁洛尔的主要人体代谢物双醋洛尔的临床药理学及血药浓度观察
Br J Clin Pharmacol. 1981 Oct;12(4):561-5. doi: 10.1111/j.1365-2125.1981.tb01265.x.
2
Antihypertensive effect of diacetolol in essential hypertension.双醋洛尔对原发性高血压的降压作用。
Br J Clin Pharmacol. 1982 Apr;13(4):533-7. doi: 10.1111/j.1365-2125.1982.tb01417.x.
3
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.醋丁洛尔。其药理学特性及在高血压、心绞痛和心律失常治疗中的疗效综述。
Drugs. 1985 Jun;29(6):531-69. doi: 10.2165/00003495-198529060-00003.
4
Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.β-肾上腺素能受体拮抗剂的临床药代动力学。最新进展。
Clin Pharmacokinet. 1987 May;12(5):305-20. doi: 10.2165/00003088-198712050-00001.
5
Acebutolol in hypertension: relationships between drug concentration and effects.
Eur J Clin Pharmacol. 1978 Dec 18;14(6):383-90. doi: 10.1007/BF00716378.
本文引用的文献
1
HUMAN ACETYLATION POLYMORPHISM.人类乙酰化多态性
J Lab Clin Med. 1964 Mar;63:394-403.
2
Genetic control of isoniazid metabolism in man.人体中异烟肼代谢的遗传控制。
Br Med J. 1960 Aug 13;2(5197):485-91. doi: 10.1136/bmj.2.5197.485.
3
The polymorphic acetylation of dapsone in man.氨苯砜在人体内的多态性乙酰化作用。
Clin Pharmacol Ther. 1971 Mar-Apr;12(2):225-38. doi: 10.1002/cpt1971122part1225.
4
An improved and simplified method of detecting the acetylator phenotype.一种检测乙酰化酶表型的改良简化方法。
J Med Genet. 1969 Dec;6(4):405-7. doi: 10.1136/jmg.6.4.405.
5
Antiarrhythmic potency of N-acetylprocainamide.N-乙酰普鲁卡因胺的抗心律失常效能
Clin Pharmacol Ther. 1975 Feb;17(2):134-40. doi: 10.1002/cpt1975172134.
6
Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.肼屈嗪诱发的类狼疮综合征患者的乙酰化酶表型
Acta Med Scand. 1976;200(5):367-71. doi: 10.1111/j.0954-6820.1976.tb08248.x.
7
Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man.醋丁洛尔及其主要代谢产物在血浆和尿液中的定量分析以及对其在人体处置动力学的初步观察。
Res Commun Chem Pathol Pharmacol. 1976 Sep;15(1):31-51.
8
Acebutolol metabolite plasma concentration during chronic oral therapy.慢性口服治疗期间醋丁洛尔代谢物的血浆浓度
Br J Clin Pharmacol. 1977 Oct;4(5):519-22. doi: 10.1111/j.1365-2125.1977.tb00779.x.
9
High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite.
J Chromatogr. 1977 Aug 1;138(1):183-91. doi: 10.1016/s0021-9673(00)98009-9.
10
Spontaneous systemic lupus erythematosus and acelylator phenotype.
Acta Med Scand. 1977;201(3):223-6. doi: 10.1111/j.0954-6820.1977.tb15686.x.
Zotero 插件